NCT07086430Completed
Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis
Source: ClinicalTrials.gov · Last updated 25 Jul 2025
Brief summary (registry, in English)
It was VAT volume predict patient outcome, while VAT density predicted baseline membrane function in PD patients and reflected peritoneal vascular density and local inflammation status.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 358 (actual)
- First submitted
- 14 Jul 2025
- Start date
- 21 Jul 2015
- Primary completion date
- 11 Jul 2023
- Lead sponsor
- RenJi Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT07086430
What you commit to
- Study type: Observational
- Participants enrolled: 358
- From 21 Jul 2015 to the primary completion date, 11 Jul 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those with acute inflammation according to clinical signs, lab results or abdominal CT scan were excluded from the cohort.
Who the study is looking for
- The study included peritoneal dialysis patients follow up in our center who had an abdominal CT scan within 2 weeks before PD catheter incubation.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.